Pabco Joint Compound / Taping Compound

Manufacturer: Fibreboard-Pabco Product Category: Joint Compound / Taping Compound Years Produced: 1957–1972 Asbestos Type: Chrysotile asbestos Legal Tier: Tier 1 — Fibreboard Asbestos Compensation Trust

Product Description

Pabco Joint Compound and Pabco Taping Compound were finishing products manufactured by Fibreboard-Pabco, a building materials division operating under the Fibreboard Corporation umbrella. Sold throughout the late 1950s, 1960s, and into the early 1970s, these compounds were widely used in residential and commercial construction as a standard solution for finishing drywall seams, concealing fastener heads, and creating smooth interior wall surfaces ready for painting or decoration.

Fibreboard-Pabco was a recognized name in the postwar construction materials industry, producing a broad line of wallboard, insulation, and finishing products intended for large-scale building projects as well as individual construction work. The joint compound and taping compound lines were marketed to contractors, tradespeople, and building supply distributors across the United States during a period of significant construction expansion. The products were available in both powdered and premixed formulations and were considered general-purpose finishing materials suited for professional and semi-professional use.

Production of these compounds using asbestos-containing formulations continued from approximately 1957 through 1972, when regulatory pressure and growing awareness of asbestos hazards prompted changes to product formulations across the construction industry. The timing of manufacture places Pabco Joint Compound and Taping Compound squarely within the era when chrysotile asbestos was a common and largely unregulated additive in finishing compounds.

Asbestos Content

Pabco Joint Compound and Pabco Taping Compound contained chrysotile asbestos as a functional ingredient in their formulations. Chrysotile, sometimes referred to as white asbestos, is a serpentine-form mineral fiber that was widely favored by manufacturers of joint and taping compounds during this period for the physical properties it contributed to the finished product.

In joint compound applications, chrysotile fibers served multiple purposes. The fibrous structure of the mineral provided tensile reinforcement, helping the dried compound resist cracking as building materials expanded and contracted with temperature and humidity changes. Chrysotile also contributed to workability during application, improving the spreadability and adhesion characteristics of the wet compound. Additionally, asbestos functioned as a binder component and added bulk to the dry mixture, making the finished product easier to manufacture consistently.

These same properties made chrysotile attractive to virtually all major joint compound manufacturers during this era. However, the physical characteristics that made asbestos useful in these products — fine, durable, and highly friable mineral fibers — also made the compounds hazardous when disturbed during mixing, sanding, or demolition. The chrysotile fibers present in Pabco Joint Compound and Taping Compound were capable of becoming airborne and remaining suspended in work environments, creating an inhalation risk for anyone in the immediate vicinity of active use or disturbance of the dried material.

How Workers Were Exposed

Workers most directly exposed to Pabco Joint Compound and Pabco Taping Compound include those who worked in construction trades and industrial environments where drywall finishing was a routine part of building and renovation activity. Exposure pathways varied depending on the specific task and the phase of construction work involved.

Mixing dry powder formulations represented one significant route of exposure. Workers who opened bags of powdered compound and combined them with water to produce a workable consistency could release clouds of fine particulate matter containing chrysotile fibers into the surrounding air. Without adequate respiratory protection — which was rarely provided or required during the primary years of this product’s use — workers inhaled these airborne fibers directly.

Application and feathering of joint compound involved spreading the wet material over seams, joints, and fastener holes using knives and broad taping tools. While wet compound poses a lower immediate fiber-release risk than dry powder, application work still required workers to handle asbestos-containing material repeatedly and at close range over extended periods.

Sanding operations posed the most severe and well-documented exposure risk. After the compound dried between coats, workers sanded surfaces smooth to prepare walls for paint or additional finishing. Sanding dried joint compound releases large quantities of fine dust, and in enclosed spaces without proper ventilation, airborne fiber concentrations could reach dangerous levels. Hand sanding, pole sanding, and machine sanding all generated this hazardous dust, and workers frequently performed these tasks without respiratory protection.

Incidental and bystander exposure was also common on job sites where multiple trades worked simultaneously. Industrial workers, laborers, and other tradespeople present in the same area as drywall finishing operations could inhale airborne chrysotile fibers released by others working directly with Pabco compound products, even if they never personally handled the materials themselves.

Repeated or prolonged inhalation of chrysotile asbestos fibers is associated with the development of serious and potentially fatal diseases, including mesothelioma, asbestosis, lung cancer, and other asbestos-related conditions. These diseases typically have latency periods of 20 to 50 years between initial exposure and clinical diagnosis, meaning workers exposed to Pabco Joint Compound during the product’s manufacturing years between 1957 and 1972 may only now be receiving diagnoses related to those exposures.

Documented Trust Fund / Legal Options

Individuals diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related diseases following exposure to Pabco Joint Compound or Pabco Taping Compound have a documented legal remedy available through the Fibreboard Asbestos Compensation Trust.

Fibreboard Corporation established its asbestos compensation trust as part of the bankruptcy and reorganization process driven by the volume of asbestos injury claims accumulated against the company. The trust was created to provide compensation to individuals harmed by Fibreboard-manufactured and Fibreboard-distributed products, including the Pabco line of joint and taping compounds.

Pabco Joint Compound and Pabco Taping Compound are named products eligible for claim submission with the Fibreboard Asbestos Compensation Trust. Claimants may be eligible to file under several standard claim categories typically recognized by the trust, which generally include:

• Mesothelioma claims
• Lung cancer claims (with documented asbestos exposure history)
• Asbestosis and other nonmalignant disease claims
• Wrongful death claims filed on behalf of deceased individuals whose exposure history included Pabco products

The trust filing process requires documentation of exposure to the specific Fibreboard-Pabco product, a confirmed medical diagnosis of an asbestos-related disease, and supporting occupational history connecting the claimant to the product’s years of manufacture and use. Experienced asbestos attorneys can assist eligible individuals and their families in gathering the necessary documentation, including employment records, co-worker affidavits, and medical records, to support a complete and timely filing.

Individuals who believe they were exposed to Pabco Joint Compound or Pabco Taping Compound during occupational activities should consult with a qualified asbestos litigation attorney to evaluate eligibility and applicable filing deadlines under the Fibreboard Asbestos Compensation Trust’s claims procedures.